Number of Participants With Serious Adverse Events (SAEs), Unsolicited Adverse Events Associated With New Onset of Chronic Disease (NOCD) or Medically Attended Adverse Events (MAAEs);Number of Participants With Solicited Local and Systemic Adverse Events;Number of Participants With Unsolicited Adverse Events

Number of Participants With Serious Adverse Events (SAEs), Unsolicited Adverse Events Associated With New Onset of Chronic Disease (NOCD) or Medically Attended Adverse Events (MAAEs);Number of Participants With Solicited Local and Systemic Adverse Events;Number of Participants With Unsolicited Adverse Events

Percentages of participants reporting adverse events;Percentages of participants reporting medically attended adverse events;Percentages of participants reporting new onset of chronic disease;Percentages of participants reporting serious adverse events;Percentages of participants reporting solicited local adverse events;Percentages of participants reporting solicited systemic adverse events;Percentages of participants with abnormal safety laboratory test values;Percentages of participants with abnormal vital sign assessments

Percentages of participants reporting adverse events;Percentages of participants reporting medically attended adverse events;Percentages of participants reporting new onset of chronic disease;Percentages of participants reporting serious adverse events;Percentages of participants reporting solicited local adverse events;Percentages of participants reporting solicited systemic adverse events;Percentages of participants with abnormal safety laboratory test values;Percentages of participants with abnormal vital sign assessments